Global Postoperative Pain Therapeutics Market Growth 2025-2031
The global Postoperative Pain Therapeutics market size is predicted to grow from US$ 10660 million in 2025 to US$ 12510 million in 2031; it is expected to grow at a CAGR of 2.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
As the global healthcare space is seeing a palpable shift toward a 'value-based care' model, postoperative pain management is gaining its very own eminence.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Postoperative Pain Therapeutics Industry Forecast” looks at past sales and reviews total world Postoperative Pain Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Postoperative Pain Therapeutics sales for 2025 through 2031. With Postoperative Pain Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Postoperative Pain Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Postoperative Pain Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Postoperative Pain Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Postoperative Pain Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Postoperative Pain Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Postoperative Pain Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Postoperative Pain Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Postoperative Pain Therapeutics market?
What factors are driving Postoperative Pain Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Postoperative Pain Therapeutics market opportunities vary by end market size?
How does Postoperative Pain Therapeutics break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
As the global healthcare space is seeing a palpable shift toward a 'value-based care' model, postoperative pain management is gaining its very own eminence.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Postoperative Pain Therapeutics Industry Forecast” looks at past sales and reviews total world Postoperative Pain Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Postoperative Pain Therapeutics sales for 2025 through 2031. With Postoperative Pain Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Postoperative Pain Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Postoperative Pain Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Postoperative Pain Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Postoperative Pain Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Postoperative Pain Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Postoperative Pain Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Postoperative Pain Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral
- Intramuscular
- Intravenous
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mallinckrodt Pharmaceuticals
- Pacira BioSciences
- Trevena
- Heron Therapeutics
- Pfizer
- Teva Pharmaceutical Industries
- Novartis
- Camarus
- Eli Lilly
- Bayer AG
What is the 10-year outlook for the global Postoperative Pain Therapeutics market?
What factors are driving Postoperative Pain Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Postoperative Pain Therapeutics market opportunities vary by end market size?
How does Postoperative Pain Therapeutics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Postoperative Pain Therapeutics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Postoperative Pain Therapeutics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Postoperative Pain Therapeutics by Country/Region, 2020, 2024 & 2031
2.2 Postoperative Pain Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Intramuscular
2.2.3 Intravenous
2.2.4 Others
2.3 Postoperative Pain Therapeutics Sales by Type
2.3.1 Global Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
2.3.2 Global Postoperative Pain Therapeutics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Postoperative Pain Therapeutics Sale Price by Type (2020-2025)
2.4 Postoperative Pain Therapeutics Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Others
2.5 Postoperative Pain Therapeutics Sales by Application
2.5.1 Global Postoperative Pain Therapeutics Sale Market Share by Application (2020-2025)
2.5.2 Global Postoperative Pain Therapeutics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Postoperative Pain Therapeutics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Postoperative Pain Therapeutics Breakdown Data by Company
3.1.1 Global Postoperative Pain Therapeutics Annual Sales by Company (2020-2025)
3.1.2 Global Postoperative Pain Therapeutics Sales Market Share by Company (2020-2025)
3.2 Global Postoperative Pain Therapeutics Annual Revenue by Company (2020-2025)
3.2.1 Global Postoperative Pain Therapeutics Revenue by Company (2020-2025)
3.2.2 Global Postoperative Pain Therapeutics Revenue Market Share by Company (2020-2025)
3.3 Global Postoperative Pain Therapeutics Sale Price by Company
3.4 Key Manufacturers Postoperative Pain Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Postoperative Pain Therapeutics Product Location Distribution
3.4.2 Players Postoperative Pain Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POSTOPERATIVE PAIN THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic Postoperative Pain Therapeutics Market Size by Geographic Region (2020-2025)
4.1.1 Global Postoperative Pain Therapeutics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Postoperative Pain Therapeutics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Postoperative Pain Therapeutics Market Size by Country/Region (2020-2025)
4.2.1 Global Postoperative Pain Therapeutics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Postoperative Pain Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Postoperative Pain Therapeutics Sales Growth
4.4 APAC Postoperative Pain Therapeutics Sales Growth
4.5 Europe Postoperative Pain Therapeutics Sales Growth
4.6 Middle East & Africa Postoperative Pain Therapeutics Sales Growth
5 AMERICAS
5.1 Americas Postoperative Pain Therapeutics Sales by Country
5.1.1 Americas Postoperative Pain Therapeutics Sales by Country (2020-2025)
5.1.2 Americas Postoperative Pain Therapeutics Revenue by Country (2020-2025)
5.2 Americas Postoperative Pain Therapeutics Sales by Type (2020-2025)
5.3 Americas Postoperative Pain Therapeutics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Postoperative Pain Therapeutics Sales by Region
6.1.1 APAC Postoperative Pain Therapeutics Sales by Region (2020-2025)
6.1.2 APAC Postoperative Pain Therapeutics Revenue by Region (2020-2025)
6.2 APAC Postoperative Pain Therapeutics Sales by Type (2020-2025)
6.3 APAC Postoperative Pain Therapeutics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Postoperative Pain Therapeutics by Country
7.1.1 Europe Postoperative Pain Therapeutics Sales by Country (2020-2025)
7.1.2 Europe Postoperative Pain Therapeutics Revenue by Country (2020-2025)
7.2 Europe Postoperative Pain Therapeutics Sales by Type (2020-2025)
7.3 Europe Postoperative Pain Therapeutics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Postoperative Pain Therapeutics by Country
8.1.1 Middle East & Africa Postoperative Pain Therapeutics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Postoperative Pain Therapeutics Revenue by Country (2020-2025)
8.2 Middle East & Africa Postoperative Pain Therapeutics Sales by Type (2020-2025)
8.3 Middle East & Africa Postoperative Pain Therapeutics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Postoperative Pain Therapeutics
10.3 Manufacturing Process Analysis of Postoperative Pain Therapeutics
10.4 Industry Chain Structure of Postoperative Pain Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Postoperative Pain Therapeutics Distributors
11.3 Postoperative Pain Therapeutics Customer
12 WORLD FORECAST REVIEW FOR POSTOPERATIVE PAIN THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global Postoperative Pain Therapeutics Market Size Forecast by Region
12.1.1 Global Postoperative Pain Therapeutics Forecast by Region (2026-2031)
12.1.2 Global Postoperative Pain Therapeutics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Postoperative Pain Therapeutics Forecast by Type (2026-2031)
12.7 Global Postoperative Pain Therapeutics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Mallinckrodt Pharmaceuticals
13.1.1 Mallinckrodt Pharmaceuticals Company Information
13.1.2 Mallinckrodt Pharmaceuticals Postoperative Pain Therapeutics Product Portfolios and Specifications
13.1.3 Mallinckrodt Pharmaceuticals Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.1.5 Mallinckrodt Pharmaceuticals Latest Developments
13.2 Pacira BioSciences
13.2.1 Pacira BioSciences Company Information
13.2.2 Pacira BioSciences Postoperative Pain Therapeutics Product Portfolios and Specifications
13.2.3 Pacira BioSciences Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pacira BioSciences Main Business Overview
13.2.5 Pacira BioSciences Latest Developments
13.3 Trevena
13.3.1 Trevena Company Information
13.3.2 Trevena Postoperative Pain Therapeutics Product Portfolios and Specifications
13.3.3 Trevena Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Trevena Main Business Overview
13.3.5 Trevena Latest Developments
13.4 Heron Therapeutics
13.4.1 Heron Therapeutics Company Information
13.4.2 Heron Therapeutics Postoperative Pain Therapeutics Product Portfolios and Specifications
13.4.3 Heron Therapeutics Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Heron Therapeutics Main Business Overview
13.4.5 Heron Therapeutics Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Postoperative Pain Therapeutics Product Portfolios and Specifications
13.5.3 Pfizer Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Teva Pharmaceutical Industries
13.6.1 Teva Pharmaceutical Industries Company Information
13.6.2 Teva Pharmaceutical Industries Postoperative Pain Therapeutics Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Industries Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teva Pharmaceutical Industries Main Business Overview
13.6.5 Teva Pharmaceutical Industries Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Postoperative Pain Therapeutics Product Portfolios and Specifications
13.7.3 Novartis Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Camarus
13.8.1 Camarus Company Information
13.8.2 Camarus Postoperative Pain Therapeutics Product Portfolios and Specifications
13.8.3 Camarus Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Camarus Main Business Overview
13.8.5 Camarus Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Postoperative Pain Therapeutics Product Portfolios and Specifications
13.9.3 Eli Lilly Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Bayer AG
13.10.1 Bayer AG Company Information
13.10.2 Bayer AG Postoperative Pain Therapeutics Product Portfolios and Specifications
13.10.3 Bayer AG Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bayer AG Main Business Overview
13.10.5 Bayer AG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Postoperative Pain Therapeutics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Postoperative Pain Therapeutics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Postoperative Pain Therapeutics by Country/Region, 2020, 2024 & 2031
2.2 Postoperative Pain Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Intramuscular
2.2.3 Intravenous
2.2.4 Others
2.3 Postoperative Pain Therapeutics Sales by Type
2.3.1 Global Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
2.3.2 Global Postoperative Pain Therapeutics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Postoperative Pain Therapeutics Sale Price by Type (2020-2025)
2.4 Postoperative Pain Therapeutics Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Others
2.5 Postoperative Pain Therapeutics Sales by Application
2.5.1 Global Postoperative Pain Therapeutics Sale Market Share by Application (2020-2025)
2.5.2 Global Postoperative Pain Therapeutics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Postoperative Pain Therapeutics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Postoperative Pain Therapeutics Breakdown Data by Company
3.1.1 Global Postoperative Pain Therapeutics Annual Sales by Company (2020-2025)
3.1.2 Global Postoperative Pain Therapeutics Sales Market Share by Company (2020-2025)
3.2 Global Postoperative Pain Therapeutics Annual Revenue by Company (2020-2025)
3.2.1 Global Postoperative Pain Therapeutics Revenue by Company (2020-2025)
3.2.2 Global Postoperative Pain Therapeutics Revenue Market Share by Company (2020-2025)
3.3 Global Postoperative Pain Therapeutics Sale Price by Company
3.4 Key Manufacturers Postoperative Pain Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Postoperative Pain Therapeutics Product Location Distribution
3.4.2 Players Postoperative Pain Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POSTOPERATIVE PAIN THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic Postoperative Pain Therapeutics Market Size by Geographic Region (2020-2025)
4.1.1 Global Postoperative Pain Therapeutics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Postoperative Pain Therapeutics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Postoperative Pain Therapeutics Market Size by Country/Region (2020-2025)
4.2.1 Global Postoperative Pain Therapeutics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Postoperative Pain Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Postoperative Pain Therapeutics Sales Growth
4.4 APAC Postoperative Pain Therapeutics Sales Growth
4.5 Europe Postoperative Pain Therapeutics Sales Growth
4.6 Middle East & Africa Postoperative Pain Therapeutics Sales Growth
5 AMERICAS
5.1 Americas Postoperative Pain Therapeutics Sales by Country
5.1.1 Americas Postoperative Pain Therapeutics Sales by Country (2020-2025)
5.1.2 Americas Postoperative Pain Therapeutics Revenue by Country (2020-2025)
5.2 Americas Postoperative Pain Therapeutics Sales by Type (2020-2025)
5.3 Americas Postoperative Pain Therapeutics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Postoperative Pain Therapeutics Sales by Region
6.1.1 APAC Postoperative Pain Therapeutics Sales by Region (2020-2025)
6.1.2 APAC Postoperative Pain Therapeutics Revenue by Region (2020-2025)
6.2 APAC Postoperative Pain Therapeutics Sales by Type (2020-2025)
6.3 APAC Postoperative Pain Therapeutics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Postoperative Pain Therapeutics by Country
7.1.1 Europe Postoperative Pain Therapeutics Sales by Country (2020-2025)
7.1.2 Europe Postoperative Pain Therapeutics Revenue by Country (2020-2025)
7.2 Europe Postoperative Pain Therapeutics Sales by Type (2020-2025)
7.3 Europe Postoperative Pain Therapeutics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Postoperative Pain Therapeutics by Country
8.1.1 Middle East & Africa Postoperative Pain Therapeutics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Postoperative Pain Therapeutics Revenue by Country (2020-2025)
8.2 Middle East & Africa Postoperative Pain Therapeutics Sales by Type (2020-2025)
8.3 Middle East & Africa Postoperative Pain Therapeutics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Postoperative Pain Therapeutics
10.3 Manufacturing Process Analysis of Postoperative Pain Therapeutics
10.4 Industry Chain Structure of Postoperative Pain Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Postoperative Pain Therapeutics Distributors
11.3 Postoperative Pain Therapeutics Customer
12 WORLD FORECAST REVIEW FOR POSTOPERATIVE PAIN THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global Postoperative Pain Therapeutics Market Size Forecast by Region
12.1.1 Global Postoperative Pain Therapeutics Forecast by Region (2026-2031)
12.1.2 Global Postoperative Pain Therapeutics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Postoperative Pain Therapeutics Forecast by Type (2026-2031)
12.7 Global Postoperative Pain Therapeutics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Mallinckrodt Pharmaceuticals
13.1.1 Mallinckrodt Pharmaceuticals Company Information
13.1.2 Mallinckrodt Pharmaceuticals Postoperative Pain Therapeutics Product Portfolios and Specifications
13.1.3 Mallinckrodt Pharmaceuticals Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.1.5 Mallinckrodt Pharmaceuticals Latest Developments
13.2 Pacira BioSciences
13.2.1 Pacira BioSciences Company Information
13.2.2 Pacira BioSciences Postoperative Pain Therapeutics Product Portfolios and Specifications
13.2.3 Pacira BioSciences Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pacira BioSciences Main Business Overview
13.2.5 Pacira BioSciences Latest Developments
13.3 Trevena
13.3.1 Trevena Company Information
13.3.2 Trevena Postoperative Pain Therapeutics Product Portfolios and Specifications
13.3.3 Trevena Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Trevena Main Business Overview
13.3.5 Trevena Latest Developments
13.4 Heron Therapeutics
13.4.1 Heron Therapeutics Company Information
13.4.2 Heron Therapeutics Postoperative Pain Therapeutics Product Portfolios and Specifications
13.4.3 Heron Therapeutics Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Heron Therapeutics Main Business Overview
13.4.5 Heron Therapeutics Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Postoperative Pain Therapeutics Product Portfolios and Specifications
13.5.3 Pfizer Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Teva Pharmaceutical Industries
13.6.1 Teva Pharmaceutical Industries Company Information
13.6.2 Teva Pharmaceutical Industries Postoperative Pain Therapeutics Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Industries Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teva Pharmaceutical Industries Main Business Overview
13.6.5 Teva Pharmaceutical Industries Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Postoperative Pain Therapeutics Product Portfolios and Specifications
13.7.3 Novartis Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Camarus
13.8.1 Camarus Company Information
13.8.2 Camarus Postoperative Pain Therapeutics Product Portfolios and Specifications
13.8.3 Camarus Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Camarus Main Business Overview
13.8.5 Camarus Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Postoperative Pain Therapeutics Product Portfolios and Specifications
13.9.3 Eli Lilly Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Bayer AG
13.10.1 Bayer AG Company Information
13.10.2 Bayer AG Postoperative Pain Therapeutics Product Portfolios and Specifications
13.10.3 Bayer AG Postoperative Pain Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bayer AG Main Business Overview
13.10.5 Bayer AG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Postoperative Pain Therapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Postoperative Pain Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Intramuscular
Table 5. Major Players of Intravenous
Table 6. Major Players of Others
Table 7. Global Postoperative Pain Therapeutics Sales by Type (2020-2025) & (K Units)
Table 8. Global Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
Table 9. Global Postoperative Pain Therapeutics Revenue by Type (2020-2025) & ($ million)
Table 10. Global Postoperative Pain Therapeutics Revenue Market Share by Type (2020-2025)
Table 11. Global Postoperative Pain Therapeutics Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Postoperative Pain Therapeutics Sale by Application (2020-2025) & (K Units)
Table 13. Global Postoperative Pain Therapeutics Sale Market Share by Application (2020-2025)
Table 14. Global Postoperative Pain Therapeutics Revenue by Application (2020-2025) & ($ million)
Table 15. Global Postoperative Pain Therapeutics Revenue Market Share by Application (2020-2025)
Table 16. Global Postoperative Pain Therapeutics Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Postoperative Pain Therapeutics Sales by Company (2020-2025) & (K Units)
Table 18. Global Postoperative Pain Therapeutics Sales Market Share by Company (2020-2025)
Table 19. Global Postoperative Pain Therapeutics Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Postoperative Pain Therapeutics Revenue Market Share by Company (2020-2025)
Table 21. Global Postoperative Pain Therapeutics Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Postoperative Pain Therapeutics Producing Area Distribution and Sales Area
Table 23. Players Postoperative Pain Therapeutics Products Offered
Table 24. Postoperative Pain Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Postoperative Pain Therapeutics Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Postoperative Pain Therapeutics Sales Market Share Geographic Region (2020-2025)
Table 29. Global Postoperative Pain Therapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Postoperative Pain Therapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Postoperative Pain Therapeutics Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Postoperative Pain Therapeutics Sales Market Share by Country/Region (2020-2025)
Table 33. Global Postoperative Pain Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Postoperative Pain Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Postoperative Pain Therapeutics Sales by Country (2020-2025) & (K Units)
Table 36. Americas Postoperative Pain Therapeutics Sales Market Share by Country (2020-2025)
Table 37. Americas Postoperative Pain Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Postoperative Pain Therapeutics Sales by Type (2020-2025) & (K Units)
Table 39. Americas Postoperative Pain Therapeutics Sales by Application (2020-2025) & (K Units)
Table 40. APAC Postoperative Pain Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. APAC Postoperative Pain Therapeutics Sales Market Share by Region (2020-2025)
Table 42. APAC Postoperative Pain Therapeutics Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Postoperative Pain Therapeutics Sales by Type (2020-2025) & (K Units)
Table 44. APAC Postoperative Pain Therapeutics Sales by Application (2020-2025) & (K Units)
Table 45. Europe Postoperative Pain Therapeutics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Postoperative Pain Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Postoperative Pain Therapeutics Sales by Type (2020-2025) & (K Units)
Table 48. Europe Postoperative Pain Therapeutics Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Postoperative Pain Therapeutics Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Postoperative Pain Therapeutics Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Postoperative Pain Therapeutics Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Postoperative Pain Therapeutics Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Postoperative Pain Therapeutics
Table 54. Key Market Challenges & Risks of Postoperative Pain Therapeutics
Table 55. Key Industry Trends of Postoperative Pain Therapeutics
Table 56. Postoperative Pain Therapeutics Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Postoperative Pain Therapeutics Distributors List
Table 59. Postoperative Pain Therapeutics Customer List
Table 60. Global Postoperative Pain Therapeutics Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Postoperative Pain Therapeutics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Postoperative Pain Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Postoperative Pain Therapeutics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Postoperative Pain Therapeutics Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Postoperative Pain Therapeutics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Postoperative Pain Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Postoperative Pain Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Postoperative Pain Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Postoperative Pain Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Postoperative Pain Therapeutics Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Postoperative Pain Therapeutics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Postoperative Pain Therapeutics Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Postoperative Pain Therapeutics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Mallinckrodt Pharmaceuticals Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 75. Mallinckrodt Pharmaceuticals Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 76. Mallinckrodt Pharmaceuticals Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Mallinckrodt Pharmaceuticals Main Business
Table 78. Mallinckrodt Pharmaceuticals Latest Developments
Table 79. Pacira BioSciences Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 80. Pacira BioSciences Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 81. Pacira BioSciences Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Pacira BioSciences Main Business
Table 83. Pacira BioSciences Latest Developments
Table 84. Trevena Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 85. Trevena Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 86. Trevena Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Trevena Main Business
Table 88. Trevena Latest Developments
Table 89. Heron Therapeutics Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 90. Heron Therapeutics Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 91. Heron Therapeutics Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Heron Therapeutics Main Business
Table 93. Heron Therapeutics Latest Developments
Table 94. Pfizer Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 96. Pfizer Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Teva Pharmaceutical Industries Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 100. Teva Pharmaceutical Industries Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 101. Teva Pharmaceutical Industries Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Teva Pharmaceutical Industries Main Business
Table 103. Teva Pharmaceutical Industries Latest Developments
Table 104. Novartis Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 105. Novartis Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 106. Novartis Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Novartis Main Business
Table 108. Novartis Latest Developments
Table 109. Camarus Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 110. Camarus Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 111. Camarus Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Camarus Main Business
Table 113. Camarus Latest Developments
Table 114. Eli Lilly Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 115. Eli Lilly Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 116. Eli Lilly Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Eli Lilly Main Business
Table 118. Eli Lilly Latest Developments
Table 119. Bayer AG Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 120. Bayer AG Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 121. Bayer AG Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Bayer AG Main Business
Table 123. Bayer AG Latest Developments
Table 1. Postoperative Pain Therapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Postoperative Pain Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Intramuscular
Table 5. Major Players of Intravenous
Table 6. Major Players of Others
Table 7. Global Postoperative Pain Therapeutics Sales by Type (2020-2025) & (K Units)
Table 8. Global Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
Table 9. Global Postoperative Pain Therapeutics Revenue by Type (2020-2025) & ($ million)
Table 10. Global Postoperative Pain Therapeutics Revenue Market Share by Type (2020-2025)
Table 11. Global Postoperative Pain Therapeutics Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Postoperative Pain Therapeutics Sale by Application (2020-2025) & (K Units)
Table 13. Global Postoperative Pain Therapeutics Sale Market Share by Application (2020-2025)
Table 14. Global Postoperative Pain Therapeutics Revenue by Application (2020-2025) & ($ million)
Table 15. Global Postoperative Pain Therapeutics Revenue Market Share by Application (2020-2025)
Table 16. Global Postoperative Pain Therapeutics Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Postoperative Pain Therapeutics Sales by Company (2020-2025) & (K Units)
Table 18. Global Postoperative Pain Therapeutics Sales Market Share by Company (2020-2025)
Table 19. Global Postoperative Pain Therapeutics Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Postoperative Pain Therapeutics Revenue Market Share by Company (2020-2025)
Table 21. Global Postoperative Pain Therapeutics Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Postoperative Pain Therapeutics Producing Area Distribution and Sales Area
Table 23. Players Postoperative Pain Therapeutics Products Offered
Table 24. Postoperative Pain Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Postoperative Pain Therapeutics Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Postoperative Pain Therapeutics Sales Market Share Geographic Region (2020-2025)
Table 29. Global Postoperative Pain Therapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Postoperative Pain Therapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Postoperative Pain Therapeutics Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Postoperative Pain Therapeutics Sales Market Share by Country/Region (2020-2025)
Table 33. Global Postoperative Pain Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Postoperative Pain Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Postoperative Pain Therapeutics Sales by Country (2020-2025) & (K Units)
Table 36. Americas Postoperative Pain Therapeutics Sales Market Share by Country (2020-2025)
Table 37. Americas Postoperative Pain Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Postoperative Pain Therapeutics Sales by Type (2020-2025) & (K Units)
Table 39. Americas Postoperative Pain Therapeutics Sales by Application (2020-2025) & (K Units)
Table 40. APAC Postoperative Pain Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. APAC Postoperative Pain Therapeutics Sales Market Share by Region (2020-2025)
Table 42. APAC Postoperative Pain Therapeutics Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Postoperative Pain Therapeutics Sales by Type (2020-2025) & (K Units)
Table 44. APAC Postoperative Pain Therapeutics Sales by Application (2020-2025) & (K Units)
Table 45. Europe Postoperative Pain Therapeutics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Postoperative Pain Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Postoperative Pain Therapeutics Sales by Type (2020-2025) & (K Units)
Table 48. Europe Postoperative Pain Therapeutics Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Postoperative Pain Therapeutics Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Postoperative Pain Therapeutics Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Postoperative Pain Therapeutics Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Postoperative Pain Therapeutics Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Postoperative Pain Therapeutics
Table 54. Key Market Challenges & Risks of Postoperative Pain Therapeutics
Table 55. Key Industry Trends of Postoperative Pain Therapeutics
Table 56. Postoperative Pain Therapeutics Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Postoperative Pain Therapeutics Distributors List
Table 59. Postoperative Pain Therapeutics Customer List
Table 60. Global Postoperative Pain Therapeutics Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Postoperative Pain Therapeutics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Postoperative Pain Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Postoperative Pain Therapeutics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Postoperative Pain Therapeutics Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Postoperative Pain Therapeutics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Postoperative Pain Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Postoperative Pain Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Postoperative Pain Therapeutics Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Postoperative Pain Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Postoperative Pain Therapeutics Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Postoperative Pain Therapeutics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Postoperative Pain Therapeutics Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Postoperative Pain Therapeutics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Mallinckrodt Pharmaceuticals Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 75. Mallinckrodt Pharmaceuticals Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 76. Mallinckrodt Pharmaceuticals Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Mallinckrodt Pharmaceuticals Main Business
Table 78. Mallinckrodt Pharmaceuticals Latest Developments
Table 79. Pacira BioSciences Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 80. Pacira BioSciences Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 81. Pacira BioSciences Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Pacira BioSciences Main Business
Table 83. Pacira BioSciences Latest Developments
Table 84. Trevena Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 85. Trevena Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 86. Trevena Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Trevena Main Business
Table 88. Trevena Latest Developments
Table 89. Heron Therapeutics Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 90. Heron Therapeutics Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 91. Heron Therapeutics Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Heron Therapeutics Main Business
Table 93. Heron Therapeutics Latest Developments
Table 94. Pfizer Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 96. Pfizer Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Teva Pharmaceutical Industries Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 100. Teva Pharmaceutical Industries Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 101. Teva Pharmaceutical Industries Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Teva Pharmaceutical Industries Main Business
Table 103. Teva Pharmaceutical Industries Latest Developments
Table 104. Novartis Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 105. Novartis Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 106. Novartis Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Novartis Main Business
Table 108. Novartis Latest Developments
Table 109. Camarus Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 110. Camarus Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 111. Camarus Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Camarus Main Business
Table 113. Camarus Latest Developments
Table 114. Eli Lilly Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 115. Eli Lilly Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 116. Eli Lilly Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Eli Lilly Main Business
Table 118. Eli Lilly Latest Developments
Table 119. Bayer AG Basic Information, Postoperative Pain Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 120. Bayer AG Postoperative Pain Therapeutics Product Portfolios and Specifications
Table 121. Bayer AG Postoperative Pain Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Bayer AG Main Business
Table 123. Bayer AG Latest Developments
LIST OF FIGURES
Figure 1. Picture of Postoperative Pain Therapeutics
Figure 2. Postoperative Pain Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Postoperative Pain Therapeutics Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Postoperative Pain Therapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Postoperative Pain Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Postoperative Pain Therapeutics Sales Market Share by Country/Region (2024)
Figure 10. Postoperative Pain Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Intramuscular
Figure 13. Product Picture of Intravenous
Figure 14. Product Picture of Others
Figure 15. Global Postoperative Pain Therapeutics Sales Market Share by Type in 2025
Figure 16. Global Postoperative Pain Therapeutics Revenue Market Share by Type (2020-2025)
Figure 17. Postoperative Pain Therapeutics Consumed in Hospital Pharmacies
Figure 18. Global Postoperative Pain Therapeutics Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 19. Postoperative Pain Therapeutics Consumed in Retail Pharmacies
Figure 20. Global Postoperative Pain Therapeutics Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 21. Postoperative Pain Therapeutics Consumed in Online Pharmacies
Figure 22. Global Postoperative Pain Therapeutics Market: Online Pharmacies (2020-2025) & (K Units)
Figure 23. Postoperative Pain Therapeutics Consumed in Others
Figure 24. Global Postoperative Pain Therapeutics Market: Others (2020-2025) & (K Units)
Figure 25. Global Postoperative Pain Therapeutics Sale Market Share by Application (2024)
Figure 26. Global Postoperative Pain Therapeutics Revenue Market Share by Application in 2025
Figure 27. Postoperative Pain Therapeutics Sales by Company in 2025 (K Units)
Figure 28. Global Postoperative Pain Therapeutics Sales Market Share by Company in 2025
Figure 29. Postoperative Pain Therapeutics Revenue by Company in 2025 ($ millions)
Figure 30. Global Postoperative Pain Therapeutics Revenue Market Share by Company in 2025
Figure 31. Global Postoperative Pain Therapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Postoperative Pain Therapeutics Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Postoperative Pain Therapeutics Sales 2020-2025 (K Units)
Figure 34. Americas Postoperative Pain Therapeutics Revenue 2020-2025 ($ millions)
Figure 35. APAC Postoperative Pain Therapeutics Sales 2020-2025 (K Units)
Figure 36. APAC Postoperative Pain Therapeutics Revenue 2020-2025 ($ millions)
Figure 37. Europe Postoperative Pain Therapeutics Sales 2020-2025 (K Units)
Figure 38. Europe Postoperative Pain Therapeutics Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Postoperative Pain Therapeutics Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Postoperative Pain Therapeutics Revenue 2020-2025 ($ millions)
Figure 41. Americas Postoperative Pain Therapeutics Sales Market Share by Country in 2025
Figure 42. Americas Postoperative Pain Therapeutics Revenue Market Share by Country (2020-2025)
Figure 43. Americas Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
Figure 44. Americas Postoperative Pain Therapeutics Sales Market Share by Application (2020-2025)
Figure 45. United States Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Postoperative Pain Therapeutics Sales Market Share by Region in 2025
Figure 50. APAC Postoperative Pain Therapeutics Revenue Market Share by Region (2020-2025)
Figure 51. APAC Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
Figure 52. APAC Postoperative Pain Therapeutics Sales Market Share by Application (2020-2025)
Figure 53. China Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 57. India Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Postoperative Pain Therapeutics Sales Market Share by Country in 2025
Figure 61. Europe Postoperative Pain Therapeutics Revenue Market Share by Country (2020-2025)
Figure 62. Europe Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
Figure 63. Europe Postoperative Pain Therapeutics Sales Market Share by Application (2020-2025)
Figure 64. Germany Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 65. France Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Postoperative Pain Therapeutics Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Postoperative Pain Therapeutics Sales Market Share by Application (2020-2025)
Figure 72. Egypt Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Postoperative Pain Therapeutics in 2025
Figure 78. Manufacturing Process Analysis of Postoperative Pain Therapeutics
Figure 79. Industry Chain Structure of Postoperative Pain Therapeutics
Figure 80. Channels of Distribution
Figure 81. Global Postoperative Pain Therapeutics Sales Market Forecast by Region (2026-2031)
Figure 82. Global Postoperative Pain Therapeutics Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Postoperative Pain Therapeutics Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Postoperative Pain Therapeutics Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Postoperative Pain Therapeutics Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Postoperative Pain Therapeutics Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Postoperative Pain Therapeutics
Figure 2. Postoperative Pain Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Postoperative Pain Therapeutics Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Postoperative Pain Therapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Postoperative Pain Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Postoperative Pain Therapeutics Sales Market Share by Country/Region (2024)
Figure 10. Postoperative Pain Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Intramuscular
Figure 13. Product Picture of Intravenous
Figure 14. Product Picture of Others
Figure 15. Global Postoperative Pain Therapeutics Sales Market Share by Type in 2025
Figure 16. Global Postoperative Pain Therapeutics Revenue Market Share by Type (2020-2025)
Figure 17. Postoperative Pain Therapeutics Consumed in Hospital Pharmacies
Figure 18. Global Postoperative Pain Therapeutics Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 19. Postoperative Pain Therapeutics Consumed in Retail Pharmacies
Figure 20. Global Postoperative Pain Therapeutics Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 21. Postoperative Pain Therapeutics Consumed in Online Pharmacies
Figure 22. Global Postoperative Pain Therapeutics Market: Online Pharmacies (2020-2025) & (K Units)
Figure 23. Postoperative Pain Therapeutics Consumed in Others
Figure 24. Global Postoperative Pain Therapeutics Market: Others (2020-2025) & (K Units)
Figure 25. Global Postoperative Pain Therapeutics Sale Market Share by Application (2024)
Figure 26. Global Postoperative Pain Therapeutics Revenue Market Share by Application in 2025
Figure 27. Postoperative Pain Therapeutics Sales by Company in 2025 (K Units)
Figure 28. Global Postoperative Pain Therapeutics Sales Market Share by Company in 2025
Figure 29. Postoperative Pain Therapeutics Revenue by Company in 2025 ($ millions)
Figure 30. Global Postoperative Pain Therapeutics Revenue Market Share by Company in 2025
Figure 31. Global Postoperative Pain Therapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Postoperative Pain Therapeutics Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Postoperative Pain Therapeutics Sales 2020-2025 (K Units)
Figure 34. Americas Postoperative Pain Therapeutics Revenue 2020-2025 ($ millions)
Figure 35. APAC Postoperative Pain Therapeutics Sales 2020-2025 (K Units)
Figure 36. APAC Postoperative Pain Therapeutics Revenue 2020-2025 ($ millions)
Figure 37. Europe Postoperative Pain Therapeutics Sales 2020-2025 (K Units)
Figure 38. Europe Postoperative Pain Therapeutics Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Postoperative Pain Therapeutics Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Postoperative Pain Therapeutics Revenue 2020-2025 ($ millions)
Figure 41. Americas Postoperative Pain Therapeutics Sales Market Share by Country in 2025
Figure 42. Americas Postoperative Pain Therapeutics Revenue Market Share by Country (2020-2025)
Figure 43. Americas Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
Figure 44. Americas Postoperative Pain Therapeutics Sales Market Share by Application (2020-2025)
Figure 45. United States Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Postoperative Pain Therapeutics Sales Market Share by Region in 2025
Figure 50. APAC Postoperative Pain Therapeutics Revenue Market Share by Region (2020-2025)
Figure 51. APAC Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
Figure 52. APAC Postoperative Pain Therapeutics Sales Market Share by Application (2020-2025)
Figure 53. China Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 57. India Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Postoperative Pain Therapeutics Sales Market Share by Country in 2025
Figure 61. Europe Postoperative Pain Therapeutics Revenue Market Share by Country (2020-2025)
Figure 62. Europe Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
Figure 63. Europe Postoperative Pain Therapeutics Sales Market Share by Application (2020-2025)
Figure 64. Germany Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 65. France Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Postoperative Pain Therapeutics Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Postoperative Pain Therapeutics Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Postoperative Pain Therapeutics Sales Market Share by Application (2020-2025)
Figure 72. Egypt Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Postoperative Pain Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Postoperative Pain Therapeutics in 2025
Figure 78. Manufacturing Process Analysis of Postoperative Pain Therapeutics
Figure 79. Industry Chain Structure of Postoperative Pain Therapeutics
Figure 80. Channels of Distribution
Figure 81. Global Postoperative Pain Therapeutics Sales Market Forecast by Region (2026-2031)
Figure 82. Global Postoperative Pain Therapeutics Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Postoperative Pain Therapeutics Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Postoperative Pain Therapeutics Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Postoperative Pain Therapeutics Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Postoperative Pain Therapeutics Revenue Market Share Forecast by Application (2026-2031)
